Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety Study of Human Embryonic Stem Cell Derived Mesenchymal Stem Cell (MSC)-Like Cells Transplantation in Women With Primary Ovarian Insufficiency (POI)

NCT03877471 is registered in ClinicalTrials.gov with Chinese Academy of Sciences as lead sponsor.

NCT NCT03877471
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03877471 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety Study of Human Embryonic Stem Cell Derived Mesenchymal Stem Cell (MSC)-Like Cells Transplantation in Women With Primary Ovarian Insufficiency (POI)
Lead sponsor
Chinese Academy of Sciences
Phase
Phase 1
Overall status
Unknown status
Start date
April 3, 2019
Completion date
December 31, 2021
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary ovarian insufficiency